Hospital-acquired Pneumonia Disease Diagnostics Market

Request Customization

Hospital-acquired Pneumonia Disease Diagnostics Market Research Report – Segmentation by Type (Culture-based Diagnostic Tests, Molecular Diagnostic Tests, Biomarker-based Assays, Point-of-care (POC) Testing); by Application (Hospitals, Diagnostic Laboratories, Academic and Research Institutes); and Region - Size, Share, Growth Analysis | Forecast (2025– 2030)

Published: 2024 - Jul

Report Code: VMR-17258

Region: Global

Historic Range: 2021-2023

Forecast: 2024-2030

Format: Excel and PDF

Chapter 1. Report Scope & Methodology

Market Segmentation

1.1 Scope, Assumptions & Limitations
1.2 Research Methodology
1.3 Primary Sources
1.4 Secondary Sources

Chapter 2. Executive Summary

Market Segmentation

2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis

📥 Download Sample Report

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

FAQ's

The market is driven by rising demand for rapid and accurate diagnostic solutions, fueled by increasing prevalence of infectious and chronic diseases. Advancements in molecular diagnostics, point-of-care testing, and personalized medicine are further accelerating adoption.

High costs of advanced diagnostic technologies and sustainability pressures limit accessibility, especially in developing regions. Additionally, intense competition and regulatory complexities make it difficult for smaller players to sustain growth.

Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Qiagen, Becton, Dickinson and Company (BD), Hologic Inc., PerkinElmer Inc. etc.

North America holds the largest share, supported by advanced healthcare infrastructure and high diagnostic adoption rates. Strong R&D investments and regulatory approvals continue to reinforce its dominance

Asia-Pacific is the fastest-growing region due to rapid healthcare expansion and rising awareness of early disease detection. Increasing investments in hospital infrastructure and diagnostic research make it the most dynamic growth hub.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe